Search Results for: PULMONARY DELIVERY Pulmonary Delivery of
Articles
3M Celebrates 25th Anniversary of Breath-Actuated Inaher August 25, 2014
It’s been happening about once every 6.6 seconds for the past 25 years, and you probably didn’t even realize it....Rexam Healthcare Devices Becomes Nemera; Renews Commitment July 8, 2014
It was announced today that the healthcare business formerly known as Rexam Healthcare Devices has become Nemera. This name change...MannKind Corporation Announces FDA Approval of Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes June 30, 2014
MannKind Corporation (Nasdaq:MNKD) recently announced that the US Food & Drug Administration (FDA) has approved AFREZZA (insulin human) Inhalation Powder...EXECUTIVE INTERVIEW - The Integration of Bend Research With Capsugel Dosage Form Solutions (DFS) June 4, 2014
Drug Development Executive: Rod Ray, former Bend Research CEO and now a member of Capsugel’s Scientific and Business Advisory Board, talks about the enhanced capabilities of Capsugel DFS and the advantages offered to companies developing new and/or enhanced medicines.
USPTO Grants New Inhaler Patent April 14, 2014
Hovione recently announced that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost...SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Early-Stage Partnerships Are On The Rise April 2, 2014
Contributor Cindy H. Dubin asked leading CMOs and CDMOs to describe the value-added services they offer with respect to formulation and manufacturing. Solving challenges of insufficient solubility, poor stability, identifying excipient candidates, and particle design topped their list of offerings.
FIXED-DOSE COMBINATIONS - Fixed-Dose Combination Products – A Review (Part 2 – Analysis) April 1, 2014
Tugrul T. Kararli, PhD, MBA, Kurt Sedo, and Josef Bossart, PhD, believe the pharmaceutical industry has been paying increasing attention to the potential of Fixed-Dose Combination products, and in a series of three articles, examine the past, present, and future of these products with the intent of understanding their whats and whys.
Hovione’s New Inhalation Capsule Filling Machine Fills Market Gap December 11, 2013
Hovione recently announced the expansion of its inhalation drug product development services with the introduction of a high-precision MG2 FlexaLAB...BIOAVAILABILITY ENHANCEMENT - Navigating a Broad Spectrum of Solubilization Technologies: Part II of III October 15, 2013
Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc., continues his multiple-part series discussing today’s most challenging issues in solubility.
THERAPEUTIC FOCUS - New Therapeutics for Aggressive Brain Cancers October 3, 2013
Jeffrey Bacha, MBA, says glioblastoma is one of the most common and fatal brain cancers, and new therapies to treat this disease are urgently needed. New approaches, such as vaccines and immunotherapies, have promising results, and to be most effective, will need to be used in combination with a chemotherapeutic.
EPO Grants Hovione New Inhaler Patent September 18, 2013
Hovione recently announced the European Patent Office has granted a patent for Hovione’s XCaps, a dry powder inhaler (DPI). XCaps...Adamis Pharmaceuticals Signs Agreement to Acquire 3M’s Technology August 11, 2013
Adamis Pharmaceuticals Corporation recently announced it has entered into an agreement to exclusively license and, with additional payment, fully acquire...FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
FORMULATION DEVELOPMENT - Bioavailability Enhancement Strategies & Opportunities March 13, 2013
Frost & Sullivan Analyst Ruplekha Choudhurie reviews some BA approaches that are being developed by a number of companies that can mitigate the biological, physical, and chemical barriers for effective delivery of poorly soluble and permeable drugs.
3/6/2013 February 28, 2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...2/27/2012 February 25, 2013
BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate...1/16/2013 January 14, 2013
BIND Biosciences & Amgen Sign Worldwide Development & Commercialization Agreement BIND Biosciences recently announced it has entered into a global...Catalent Makes Major Inhalation Capabilities Investment January 14, 2013
Catalent Pharma Solutions recently announced it will make a major investment to expand its industry-leading inhalation drug development, delivery,...12/12/2012 December 10, 2012
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs The challenges inherent in the pharmacological management of rheumatic diseases...Pearl Therapeutics Issued US Patent on Co-Suspension Formulation Technology December 10, 2012
Pearl Therapeutics Inc. recently announced that the US Patent and Trademark Office has issued a patent on its novel co-suspension...
